生物活性 | |||
---|---|---|---|
描述 | CH7057288 is a potent and selective TRK inhibitor. In an intracranial implantation model simulating brain metastases, CH7057288 induced intracranial tumour regression and greatly improved event-free survival. CH7057288 can be used as a therapeutic agent for TRK fusion-positive cancers. The TRK receptor tyrosine kinase is expressed in a variety of cancer types, including lung and colorectal cancers, in the form of fusion proteins encoded by various fusion genes[1]. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
1.76mL 0.35mL 0.18mL |
8.78mL 1.76mL 0.88mL |
17.55mL 3.51mL 1.76mL |
参考文献 |
---|